The Gladstone Foundation is a nonprofit organization that provides financial and advisory support to Gladstone Institutes. Established in 2011, this volunteer organization is composed of dedicated leaders who understand that the search for global cures must begin with deep biological knowledge and research.
Gladstone Foundation Board of Directors
Chair
William H. Younger, Jr.
Retired Managing Director
Sutter Hill Ventures
Vice Chair
Stasia A. Obremskey
Managing Director
Rhia Ventures
Board Members
Chris Boskin
Media Consultant
Fred Craves
Founder and Managing Director
Bay City Capital
Marianne De Backer, PhD, MBA
CEO and Director
Vir Biotechnology, Inc.
Paul C. Edwards
Edwards Partners
William Evers
Managing Director
AlTi Global
Sakurako D. Fisher
Former President
San Francisco Symphony
Tom Furst
Retired CFO
SRI International
Linda Grais, MD, JD
Former President and CEO
Ocera Therapeutics
Erin Hoffmann
President and Co-Founder
Additional Ventures
Perry Karsen
Former CEO
Celgene Cellular Therapeutics
EVP and Chief Operations Officer
Celgene Corporation
Li Lu
Founder and Chairman
Himalaya Capital
Diksha Makan
Senior Vice President of Technology Strategy
ICONIQ Capital
Gary Morgenthaler
Partner
Morgenthaler Ventures
Deep V. Nishar
Managing Director
General Catalyst
Christopher R. Redlich, Jr.
Philanthropist
Steve Richardson
Consultant, Executive Management
Alexandria Real Estate Equities, Inc.
Douglas G. Scrivner
Retired General Counsel
Accenture
Deepak Srivastava, MD
President
Gladstone Institutes
Director
Roddenberry Stem Cell Center
James B. Tananbaum, MD
Founder, CEO, and Managing Director
Foresite Capital Management
R. Sanders Williams, MD
President Emeritus
Gladstone Institutes
Sharon Winslow
Attorney
Board Officers
Chris Nicholson
Secretary
Michelle Sibly
Treasurer
Robert Wicks
CEO